Skip to main content
Press release May 7, 2026

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.

Catalyst Pharmaceuticals, Inc. (CPRX)

We couldn't retrieve the full text for this release. Read it on the company's site.

Read full release on company site